Evaluation of 99mTc-UBI 29-41 scintigraphy for specific detection of experimental Staphylococcus aureus prosthetic joint infections
- 3 March 2007
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 34 (8), 1302-1309
- https://doi.org/10.1007/s00259-007-0368-7
Abstract
99mTc-UBI 29-41 (UBI), an antimicrobial peptide, specifically targets bacteria. We tested the ability of UBI to discriminate between infected and uninfected prosthetic joints using a rabbit model previously validated.Keywords
This publication has 42 references indexed in Scilit:
- Innate immunity in human boneBone, 2006
- Prosthetic Joint InfectionClinical Orthopaedics and Related Research, 2005
- Value of Preoperative Investigations in Diagnosing Prosthetic Joint Infection: Retrospective Cohort Study and Literature ReviewScandinavian Journal of Infectious Diseases, 2004
- Infection detection in mice using 99mTc-labeled HYNIC and N2S2 chelate conjugated to the antimicrobial peptide UBI 29-41Nuclear Medicine and Biology, 2004
- Biokinetics of 99mTc-UBI 29-41 in humansNuclear Medicine and Biology, 2004
- Trends in the treatment of orthopaedic prosthetic infectionsJournal of Antimicrobial Chemotherapy, 2004
- Evaluation of technetium-99m-ciprofloxacin (Infecton) for detecting sites of inflammation in arthritisRheumatology, 2003
- Prospective comparative study of patients with culture proven and high suspicion of adult onset septic arthritisAnnals Of The Rheumatic Diseases, 2003
- Infection of prosthetic jointsBest Practice & Research Clinical Rheumatology, 2003
- A New Model of Experimental Prosthetic Joint Infection Due to Methicillin-Resistant Staphylococcus aureus: A Microbiologic, Histopathologic, and Magnetic Resonance Imaging CharacterizationThe Journal of Infectious Diseases, 1996